Global Hybrid Imaging Market 2017-2021

Overview of the global hybrid imaging market

According to the Technavio’s analyst, the global hybrid imaging market is anticipated to grow at a steady rate and will post a CAGR of more than 8% during the forecast period. The growing adoption of positron emission tomography (PET) or computed tomography (CT) hybrid imaging will drive the growth prospects for the global hybrid imaging market until the end of 2021. The PET-CT represents one of the medical imaging modalities, which is used for early diagnosis, accurate disease staging, and acts as an effective response to the treatment of chronic conditions such as cancer. Also, new technological advancements in this hybrid imaging modality such as precise measurement for better differentiation and measurement of tumors increased data storage capabilities for oncologists to track tumor developments, and less patient movement will result in the market’s growth.

In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. One of the major factors responsible for the increasing demand for hybrid imaging modalities in this region is the availability of favorable reimbursement facilities by Centers for Medicare and Medicaid Services (CMS).

Competitive landscape and key vendors

The global hybrid imaging market is highly competitive and diversified due to the presence of a large number of regional and international vendors across the globe. These vendors are increasingly competing against each other based on factors such as aggressive pricing, product differentiation, capital support for product or technology up gradation, remote monitoring services, convenient to use, and distribution partnerships.

Key vendors in this market are -

• GE Healthcare
• Mediso
• Philips Healthcare
• Siemens Healthcare

Other prominent vendors in the market include Advanced Accelerator Applications, AGFA Healthcare, BC Technical, Cardinal Health, Carestream Health, CMR Naviscan, Cubresa, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, IBA Molecular, Mylin Medical, CMR Naviscan, Nordion, Photo Diagnostic Systems, Piramal Imaging, Positron, RadioMedix, Roses Medical & Surgical Supply, Sofie Biosciences, and Toshiba Medical Systems.

Segmentation by product type and analysis of the hybrid imaging market

• PET or CT
• SPECT or CT
• PET or MRI

The PET-CT segment accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the factors responsible for the market segment’s growth includes technological advancements, decreasing prices, increasing awareness among end-users, and availability of reimbursements.

Segmentation by application and analysis of the hybrid imaging market

• Oncology
• Cardiology
• Orthopedics

The oncology segment is one of the fastest growing segments of the market and will continue to grow for the next four years. One of the major factors responsible for the market segment’s growth is the increasing use of hybrid images in the oncological segment to understand and detect location molecules in the body as tracer decays.

Key questions answered in the report include

• What will the market size and the growth rate be in 2021?
• What are the key factors driving the global hybrid imaging market?
• What are the key market trends impacting the growth of the global hybrid imaging market?
• What are the challenges to market growth?
• Who are the key vendors in the global hybrid imaging market?
• What are the market opportunities and threats faced by the vendors in the global hybrid imaging market?
• What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
• What are the key outcomes of the five forces analysis of the global hybrid imaging market?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

• Global 3D Medical Imaging Equipment Market 2016-2020
• Global Interventional Cardiology Market 2017-2021
• Global Nuclear Medicine Market 2016-2020
• Global Vascular Guidewires Market 2016-2020